COMMUNIQUÉS West-GlobeNewswire

Hyloris Broadens Pipeline with new Product Candidate for Vulvar Lichen Sclerosus (VLS)

18/01/2024 - 19:00

Hyloris Broadens Pipeline with new Product Candidate for Vulvar Lichen Sclerosus (VLS) Equal Partnership with AFT Pharmaceuticals for Development of a Drug Releasing Mucoadhesive Film for VLS (HY-091) Limited [...]

Hyloris Elargit son Portefeuille de Produits avec un Nouveau Produit Candidat pour le Lichen Scléreux Vulvaire (LSV)

18/01/2024 - 19:00

Co-Partenariat avec AFT Pharmaceuticals pour le Développement d'un Film Muco-adhésif Libérant des Médicaments pour le LSV (HY-091) Disponibilité Limitée des Options Thérapeutiques Approuvées dans les LSV Liège, Belgique [...]

Cytokinetics Announces New Data From FOREST-HCM to be Presented at CMR 2024

18/01/2024 - 19:00

SOUTH SAN FRANCISCO, Calif., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced an upcoming presentation at CMR 2024 taking place online and in person in London, UK from January [...]

Optinose Announces the Publication of ReOpen Phase 3 Clinical Trial Program Evaluating XHANCE in the Journal of Allergy and Clinical Immunology: In Practice

18/01/2024 - 18:00

XHANCE significantly reduced both symptoms and sinus opacification in participants with chronic sinusitis (chronic rhinosinusitis) in two randomized controlled Phase 3 Clinical Trials (ReOpen1 and ReOpen2) FDA [...]

Pressure BioSciences Reports New Client Launching Around UltraShear Nanoemulsions Platform with $300,000-plus Product Order

18/01/2024 - 17:26

VICAR Holdings LLC to Purchase Over 10,000 Bottles of PBIO’s Best-in-Class Nano-CBD Topical Spray in 2024; Aided by the Recent Acquisition of Its New Uncle Buds Business Unit, PBIO Expects Consumer Products to Continue [...]

ALK completes first part of phase 1 trial with peanut SLIT-tablet

18/01/2024 - 15:34

The trial now progresses into its second part, expected to complete later in 2024. ALK to submit a protocol amendment for Phase 1-2 efficacy trial extension. ALK ( ALKB:DC / OMX: ALK B / AKBLF ) announced today that it [...]

Sharps Technology Signs LOI with Roncadelle Operations Intended to Open Worldwide Sales and Distribution Opportunities for Safe Drug Delivery Systems

18/01/2024 - 15:00

Agreement would result in Sharps and Roncadelle Joining Forces to Access Global Healthcare Organizations Through More Than 30 Sales Partners worldwide NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc [...]

Vivtex and AI Proteins Enter Strategic R&D Collaboration to Develop Novel, Oral Biologic Therapies for Inflammatory Diseases

18/01/2024 - 15:00

Cambridge/Boston, MA, USA – 18 th January 2024 . Vivtex Corporation (“Vivtex”), a biotech company aiming to transform the development of oral biologic therapies for major diseases, and AI Proteins, Inc., a growing [...]

T2 Biosystems Announces Participation in NIH-funded Antibacterial Resistance Leadership Group (ARLG) Pilot Study for Pneumonia Patients

18/01/2024 - 15:00

LEXINGTON, Mass., Jan. 18, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced participation in the [...]

Teladoc Health highlights progress in advancing care access, sustainability in new report

18/01/2024 - 15:00

Industry leader releases fourth annual Corporate Social Responsibly (CSR) report PURCHASE, NY, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, today [...]

TerrAscend to Present at the FONDS PROFESSIONELL KONGRESS in Germany on January 25th

18/01/2024 - 15:00

TORONTO, Jan. 18, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, today announced that its executive management team will [...]

NEXGEL to Present at The Microcap Conference, January 30th through February 1st

18/01/2024 - 15:00

LANGHORNE, Pa., Jan. 18, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer [...]

Cannabix Quantifies Marijuana Breath Samples from Maryland Green Lab – Results Analyzed at North Louisiana Criminalistics Laboratory

18/01/2024 - 14:45

VANCOUVER, British Columbia, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices reports that [...]

Elevar Therapeutics To Present Two Posters From Phase 3 CARES-310 Study at 2024 ASCO Gastrointestinal Cancers Symposium

18/01/2024 - 14:45

A post hoc analysis found the efficacy of camrelizumab plus rivoceranib was superior to sorafenib regardless of baseline liver function as measured by both albumin-bilirubin grade and Child-Pugh class Another analysis, [...]

Surrozen Provides Corporate Update on Clinical Programs

18/01/2024 - 14:30

Announces strategic prioritization of clinical programs to focus on development of SZN-043 for Alcohol-Associated Hepatitis SZN-043 - Completed enrollment for the Phase 1a clinical trial in chronic liver disease [...]

XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisition

18/01/2024 - 14:30

XOMA provided an $8 million non-dilutive royalty capital solution to Talphera XOMA will receive a 15% royalty on all commercial sales and a significant portion of the 75% royalty generated by U.S. Department of Defense [...]

Adial Announces Appointment of Tony Goodman as Chief Operating Officer

18/01/2024 - 14:30

Highly Experienced Pharma Commercial and Business Development Executive in Addiction Treatment Space Joins Leadership Team While Continuing as Board Member Charlottesville, Va., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Adial [...]

UK’s largest independent chemical manufacturer takes drug testing in-house with Intelligent Fingerprinting Drug Screening System

18/01/2024 - 14:30

NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today [...]

Lisata Therapeutics to Present at the Sequire Investor Summit in Puerto Rico

18/01/2024 - 14:30

BASKING RIDGE, NJ, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of [...]